Blanket purchase agreement for A1C hemoglobin testing for VISN 23.
Ended Awarded Last action
- Contract number
- 36C26325N0052
- Awardee
-
Tosoh Bioscience, Inc. UEI Q9YNUD9SW2J8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $8,700
Award facts
- Opportunity
-
- 36C26324AP4364 Solicitation number
- Contract value 100% obligated
- $8,700.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Grand Island, NE 68803, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$4,260 | |
| Original award | $12,960 |
About this award
Tosoh Bioscience, Inc. (doing business as Tosoh USA) received a blanket purchase agreement (BPA) call award from Veterans Integrated Service Network 23 (VISN 23) on October 1, 2024, for hemoglobin A1C testing supplies and services. This firm fixed-price contract, valued at $8,700.48, is set to conclude on September 30, 2025, and will support clinical laboratory operations at VA facilities in the Grand Island, Nebraska area. The award is issued under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule and carries no small business set-aside designation, reflecting the specialized and non-competitive nature of the procurement.
Tosoh Bioscience is a global manufacturer of chromatographic solutions and clinical diagnostic equipment headquartered in South San Francisco, California, specializing in high-performance liquid chromatography (HPLC) testing instrumentation and hemoglobin A1C analyzers for diabetes diagnosis and management. This contract call represents a task order under a larger $2.5 million VISN 23 BPA awarded in March 2025, which provides A1C hemoglobin testing products and services through February 2026. The company serves as the prime contractor with no identified subcontractors and maintains an extensive portfolio of approximately $10.6 million in federal contract vehicles across multiple Veterans Affairs networks, supporting diabetes diagnostic capabilities and veteran healthcare delivery.
Quick answers
Who was awarded contract 36C26325N0052?
36C26325N0052 was awarded to Tosoh Bioscience, Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26325N0052 worth?
The government has obligated $8,700 on 36C26325N0052.
Is contract 36C26325N0052 an order under another contract?
Yes. 36C26325N0052 is a BPA call under V797D40130-36C26325A0001, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 36C26325N0052 competed?
The extent of competition for 36C26325N0052 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award